Laboratorios Richmond SACIF (BA:RICH) — Stock Price

AR$1555.00 ARS
▲ 1.30% today

Laboratorios Richmond SACIF (BA:RICH) is currently trading at AR$1555.00 ARS, up 1.30% today. Over the past 52 weeks, shares have ranged between AR$970.00 and AR$2165.00. This page tracks Laboratorios Richmond SACIF's live share price on the BA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Laboratorios Richmond SACIF worth.

Laboratorios Richmond SACIF (RICH) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Laboratorios Richmond SACIF's daily closing share price and trading volume on the BA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Laboratorios Richmond SACIF Income Statement — Revenue, Profit & Earnings by Year

Laboratorios Richmond SACIF's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue AR$91.79 Billion AR$84.99 Billion AR$18.47 Billion AR$16.62 Billion AR$6.18 Billion
Cost of Revenue AR$41.77 Billion AR$40.23 Billion AR$9.74 Billion AR$11.69 Billion AR$3.17 Billion
Gross Profit AR$50.02 Billion AR$44.76 Billion AR$8.73 Billion AR$4.93 Billion AR$3.01 Billion
Research & Development — — — — —
SG&A AR$13.05 Billion AR$33.22 Billion AR$2.50 Billion AR$951.10 Million AR$464.06 Million
Total Operating Expenses AR$76.09 Billion AR$73.97 Billion AR$15.43 Billion AR$14.29 Billion AR$4.67 Billion
Operating Income AR$15.71 Billion AR$11.02 Billion AR$3.04 Billion AR$2.32 Billion AR$1.51 Billion
EBITDA — — AR$2.96 Billion AR$2.51 Billion AR$1.21 Billion
EBIT — — AR$2.98 Billion AR$4.49 Billion AR$2.33 Billion
Interest Expense AR$3.29 Billion AR$11.56 Billion AR$1.43 Billion AR$744.86 Million AR$279.71 Million
Income Before Tax AR$28.58 Billion AR$-30.32 Billion AR$799.50 Million AR$1.42 Billion AR$757.70 Million
Income Tax Expense — — AR$640.10 Million AR$1.59 Billion AR$410.18 Million
Net Income AR$23.85 Billion AR$-23.63 Billion AR$163.43 Million AR$591.46 Million AR$486.24 Million

Laboratorios Richmond SACIF Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Laboratorios Richmond SACIF's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets AR$260.15 Billion AR$337.32 Billion AR$40.72 Billion AR$25.69 Billion AR$8.13 Billion
Total Current Assets AR$68.62 Billion AR$68.37 Billion AR$14.04 Billion AR$30.07 Billion AR$8.16 Billion
Cash & Equivalents — — — — —
Short-term Investments AR$2.95 Billion AR$404.16 Million AR$1.43 Billion AR$2.69 Billion AR$345.71 Million
Net Receivables AR$28.17 Billion AR$24.55 Billion AR$14.81 Billion AR$6.88 Billion AR$4.31 Billion
Inventory AR$25.39 Billion AR$34.40 Billion AR$5.18 Billion AR$7.45 Billion AR$2.43 Billion
Property, Plant & Equipment — — AR$21.79 Billion AR$15.54 Billion AR$3.04 Billion
Goodwill AR$4.16 Billion AR$5.99 Billion AR$1.02 Billion AR$531.17 Million AR$300.28 Million
Total Liabilities AR$194.80 Billion AR$287.34 Billion AR$30.50 Billion AR$20.32 Billion AR$4.75 Billion
Total Current Liabilities AR$56.84 Billion AR$79.06 Billion AR$9.03 Billion AR$18.17 Billion AR$5.36 Billion
Long-term Debt AR$22.06 Billion AR$17.31 Billion AR$18.40 Billion AR$1.19 Billion AR$901.53 Million
Net Debt AR$33.32 Billion AR$36.70 Billion AR$20.00 Billion AR$12.99 Billion AR$1.07 Billion
Total Stockholder Equity AR$64.30 Billion AR$49.10 Billion AR$10.09 Billion AR$5.29 Billion AR$3.38 Billion
Retained Earnings AR$15.58 Billion AR$-23.63 Billion AR$2.44 Billion AR$2.49 Billion AR$747.13 Million

Laboratorios Richmond SACIF Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Laboratorios Richmond SACIF generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow AR$5.62 Billion AR$-4.54 Billion AR$-4.29 Billion AR$7.27 Billion AR$-181.33 Million
Capital Expenditures AR$8.81 Billion AR$27.26 Billion AR$6.69 Billion AR$10.32 Billion AR$561.43 Million
Free Cash Flow AR$-3.19 Billion AR$-31.80 Billion AR$-11.80 Billion AR$-2.19 Billion AR$-716.66 Million
Investing Cash Flow — — AR$-7.44 Billion AR$-11.76 Billion AR$-1.06 Billion
Financing Cash Flow — — AR$1.31 Billion AR$17.77 Billion AR$1.70 Billion
Dividends Paid — — AR$508.76 Million AR$134.99 Million AR$134.99 Million
Stock-Based Compensation — — — — —
Depreciation AR$7.27 Billion AR$5.08 Billion AR$414.47 Million AR$673.20 Million AR$255.12 Million
Change in Cash AR$8.17 Billion AR$-16.45 Billion AR$-11.65 Billion AR$12.78 Billion AR$347.17 Million

Laboratorios Richmond SACIF Earnings History — EPS Actual vs. Analyst Estimates

Track Laboratorios Richmond SACIF's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 05, 2026 — — —
Nov 03, 2025 — — —
Aug 11, 2025 — — —
Mar 31, 2023 0.93 — —
Nov 09, 2022 -2.15 — —
Aug 10, 2022 5.80 — —
May 11, 2022 2.77 — —
Nov 11, 2021 -0.96 — —